Michael Polydefkis

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society

Giuseppe Lauria, Sung‐Tsang Hsieh, O. Johansson et al. · European Journal of Neurology · 2010 · 845 citations · Full text

Medicine, Neurology, Dermatopathology +9

The spectrum of neuropathy in diabetes and impaired glucose tolerance

Charlotte J. Sumner, Sanjana Sheth, Justin W. Griffin et al. · Neurology · 2003 · 708 citations

Medicine, Internal Medicine, Neurology +17

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

David Adams, Ivailo Tournev, Mark Taylor et al. · Amyloid · 2022 · 379 citations · Full text

Medicine, Neurology, Pharmacotherapy +13